JPS5363335A - Triisubstitutedd11phenyll2*3*4*55 tetrahydroo1hh33benzazepine compound - Google Patents

Triisubstitutedd11phenyll2*3*4*55 tetrahydroo1hh33benzazepine compound

Info

Publication number
JPS5363335A
JPS5363335A JP13841077A JP13841077A JPS5363335A JP S5363335 A JPS5363335 A JP S5363335A JP 13841077 A JP13841077 A JP 13841077A JP 13841077 A JP13841077 A JP 13841077A JP S5363335 A JPS5363335 A JP S5363335A
Authority
JP
Japan
Prior art keywords
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP13841077A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6225658B2 (US20080293856A1-20081127-C00150.png
Inventor
Ueinsutotsuku Jiyosefu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline LLC
Original Assignee
SmithKline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Corp filed Critical SmithKline Corp
Publication of JPS5363335A publication Critical patent/JPS5363335A/ja
Publication of JPS6225658B2 publication Critical patent/JPS6225658B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10Antioedematous agents; Diuretics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/63Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00Compounds having —CHO groups
    • C07C47/52Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D497/00Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP13841077A 1976-11-17 1977-11-16 Triisubstitutedd11phenyll2*3*4*55 tetrahydroo1hh33benzazepine compound Granted JPS5363335A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/742,965 US4160765A (en) 1976-11-17 1976-11-17 Method for 6-bromination of 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine compounds

Publications (2)

Publication Number Publication Date
JPS5363335A true JPS5363335A (en) 1978-06-06
JPS6225658B2 JPS6225658B2 (US20080293856A1-20081127-C00150.png) 1987-06-04

Family

ID=24986959

Family Applications (3)

Application Number Title Priority Date Filing Date
JP13841077A Granted JPS5363335A (en) 1976-11-17 1977-11-16 Triisubstitutedd11phenyll2*3*4*55 tetrahydroo1hh33benzazepine compound
JP57222834A Granted JPS58113153A (ja) 1976-11-17 1982-12-18 フエネチルアミン誘導体
JP61199885A Granted JPS62155218A (ja) 1976-11-17 1986-08-25 ド−パミン作用剤医薬組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP57222834A Granted JPS58113153A (ja) 1976-11-17 1982-12-18 フエネチルアミン誘導体
JP61199885A Granted JPS62155218A (ja) 1976-11-17 1986-08-25 ド−パミン作用剤医薬組成物

Country Status (37)

Country Link
US (1) US4160765A (US20080293856A1-20081127-C00150.png)
JP (3) JPS5363335A (US20080293856A1-20081127-C00150.png)
AR (1) AR224495A1 (US20080293856A1-20081127-C00150.png)
AT (1) AT362379B (US20080293856A1-20081127-C00150.png)
AU (1) AU509754B2 (US20080293856A1-20081127-C00150.png)
BE (1) BE860774A (US20080293856A1-20081127-C00150.png)
BG (1) BG30019A3 (US20080293856A1-20081127-C00150.png)
CA (1) CA1092107A (US20080293856A1-20081127-C00150.png)
CH (1) CH635079A5 (US20080293856A1-20081127-C00150.png)
CS (1) CS219333B2 (US20080293856A1-20081127-C00150.png)
CY (1) CY1246A (US20080293856A1-20081127-C00150.png)
DD (1) DD133563A5 (US20080293856A1-20081127-C00150.png)
DE (1) DE2751258A1 (US20080293856A1-20081127-C00150.png)
DK (1) DK156057C (US20080293856A1-20081127-C00150.png)
ES (1) ES464044A1 (US20080293856A1-20081127-C00150.png)
FI (1) FI67374C (US20080293856A1-20081127-C00150.png)
FR (1) FR2371430A1 (US20080293856A1-20081127-C00150.png)
GB (1) GB1595502A (US20080293856A1-20081127-C00150.png)
HU (1) HU176709B (US20080293856A1-20081127-C00150.png)
IE (1) IE46087B1 (US20080293856A1-20081127-C00150.png)
IL (1) IL53377A (US20080293856A1-20081127-C00150.png)
IN (1) IN150172B (US20080293856A1-20081127-C00150.png)
IT (1) IT1126216B (US20080293856A1-20081127-C00150.png)
LU (1) LU78513A1 (US20080293856A1-20081127-C00150.png)
MX (1) MX4682E (US20080293856A1-20081127-C00150.png)
MY (1) MY8500382A (US20080293856A1-20081127-C00150.png)
NL (2) NL185563C (US20080293856A1-20081127-C00150.png)
NO (1) NO147029C (US20080293856A1-20081127-C00150.png)
PH (2) PH13611A (US20080293856A1-20081127-C00150.png)
PL (1) PL109672B1 (US20080293856A1-20081127-C00150.png)
PT (1) PT67260B (US20080293856A1-20081127-C00150.png)
RO (1) RO72905A (US20080293856A1-20081127-C00150.png)
SE (1) SE436646B (US20080293856A1-20081127-C00150.png)
SG (1) SG31784G (US20080293856A1-20081127-C00150.png)
SU (1) SU976847A3 (US20080293856A1-20081127-C00150.png)
YU (1) YU40490B (US20080293856A1-20081127-C00150.png)
ZA (1) ZA775910B (US20080293856A1-20081127-C00150.png)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56122357A (en) * 1980-01-31 1981-09-25 Smithkline Corp 7*88amino*hydroxyy11phenyll2*3*4*55tetrahydroo 1hh33bezazepines* their manufacture and medicinal composition containing them
KR20010113006A (ko) * 2000-06-15 2001-12-24 주정호 항암제로서 유용한 n-치환된 벤즈아제피닐우레아 유도체및 그의 제조방법
JP2008501660A (ja) * 2004-06-02 2008-01-24 グラクソ グループ リミテッド ドーパミンd3受容体に対してアフィニティーを有する化合物およびその使用

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197297A (en) * 1976-11-17 1980-04-08 Smithkline Corporation 6-Halo-7,8-dihydroxy-1-(hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepines
JPS5481290A (en) * 1977-11-17 1979-06-28 Smithkline Corp Benzazepin compound
US4171359A (en) * 1978-04-12 1979-10-16 Smithkline Corporation Benz-tetrasubstituted 1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
ZA792043B (en) * 1978-05-08 1980-05-28 Scherico Ltd Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof and pharmaceutical compositions containing them
US4251525A (en) * 1979-05-25 1981-02-17 Smithkline Corporation 3-Allyl-7,8-dihydroxy-6-halo-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine derivatives
DE3065940D1 (en) * 1979-07-10 1984-01-26 Smithkline Beckman Corp Synergistic antihypertensive compositions
US4285938A (en) * 1979-10-11 1981-08-25 Smithkline Corporation 7,8-Dihydroxy-1-(sulfamylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine derivatives
US4328153A (en) * 1980-07-17 1982-05-04 Smith Kline Corporation Dopaminergic benzazepines
ATE15762T1 (de) * 1981-12-08 1985-10-15 Smithkline Beckman Corp Pharmazeutische zusammensetzungen mit gehalt an 7,8-dihydroxy-1-(hydroxy-phenyl)-2,3,4,5tetrahydro-1h-3-benzazepin-derivaten und an einem beta-adrenergischen blocker.
US4705862A (en) * 1984-10-05 1987-11-10 Smithkline Beckman Corporation Chemical processes for 2-(2-halo-3,4-dimethoxybenzyl)-5-(4-methoxyphenyl)oxazolidines
US4782163A (en) * 1984-10-05 1988-11-01 Smithkline Beckman Corporation 2-(2-halo-3,4-dimethoxybenzyl)-5-(4-methoxyphenyl)-oxazolidines
US5068326A (en) * 1989-04-03 1991-11-26 Kung Hank F Dopamine receptor ligands and imaging agents
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
JP2007516149A (ja) 2003-05-21 2007-06-21 アレックザ ファーマシューティカルズ, インコーポレイテッド 基板温度の均一性を制御する方法、および、内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
AU2004322756B2 (en) 2004-08-12 2011-04-14 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
CA2593667A1 (en) * 2005-01-24 2006-07-27 Sicor Inc. Process for the preparation of fenoldopam mesylate
US20080216828A1 (en) 2007-03-09 2008-09-11 Alexza Pharmaceuticals, Inc. Heating unit for use in a drug delivery device
CN104876869B (zh) * 2011-12-22 2017-06-30 四川科伦药物研究院有限公司 一种手性菲诺多泮的拆分方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
GB1118688A (en) * 1967-02-17 1968-07-03 Scherico Ltd Novel benzazepines and process for making same
CH498122A (de) * 1968-02-09 1970-10-31 Geigy Ag J R Verfahren zur Herstellung eines neuen Tetrahydroazepinderivates
CH555831A (de) * 1967-02-17 1974-11-15 Scherico Ltd Verfahren zur herstellung von neuen benzazepinen.
DE1695844C3 (de) * 1967-02-21 1980-01-17 Scherico Ltd., Luzern (Schweiz) l-Phenyl-23,43-tetrahydro-lH^benzazepin-Derivate und sie enthaltende pharmazeutische Zusammensetzungen
US3609138A (en) * 1967-12-22 1971-09-28 Ciba Geigy Corp 1-aryl-3-benzazepines
US4011319A (en) * 1975-07-02 1977-03-08 Smithkline Corporation Pharmaceutical compositions and methods involving benzazepine derivatives

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56122357A (en) * 1980-01-31 1981-09-25 Smithkline Corp 7*88amino*hydroxyy11phenyll2*3*4*55tetrahydroo 1hh33bezazepines* their manufacture and medicinal composition containing them
KR20010113006A (ko) * 2000-06-15 2001-12-24 주정호 항암제로서 유용한 n-치환된 벤즈아제피닐우레아 유도체및 그의 제조방법
JP2008501660A (ja) * 2004-06-02 2008-01-24 グラクソ グループ リミテッド ドーパミンd3受容体に対してアフィニティーを有する化合物およびその使用
JP4890446B2 (ja) * 2004-06-02 2012-03-07 グラクソ グループ リミテッド ドーパミンd3受容体に対してアフィニティーを有する化合物およびその使用

Also Published As

Publication number Publication date
PT67260B (en) 1979-04-18
HU176709B (en) 1981-04-28
FI773448A (fi) 1978-05-18
NL930026I1 (nl) 1993-06-01
AR224495A1 (es) 1981-12-15
NL7712567A (nl) 1978-05-19
DE2751258C2 (US20080293856A1-20081127-C00150.png) 1990-01-04
YU40490B (en) 1986-02-28
SE436646B (sv) 1985-01-14
PH14740A (en) 1981-11-20
ZA775910B (en) 1978-05-30
US4160765A (en) 1979-07-10
JPS6125697B2 (US20080293856A1-20081127-C00150.png) 1986-06-17
IL53377A (en) 1982-09-30
BG30019A3 (en) 1981-03-16
IL53377A0 (en) 1978-01-31
SG31784G (en) 1985-03-08
GB1595502A (en) 1981-08-12
LU78513A1 (US20080293856A1-20081127-C00150.png) 1978-03-20
IN150172B (US20080293856A1-20081127-C00150.png) 1982-04-07
JPS62155218A (ja) 1987-07-10
AU509754B2 (en) 1980-05-22
FI67374B (fi) 1984-11-30
JPS6366808B2 (US20080293856A1-20081127-C00150.png) 1988-12-22
NO147029C (no) 1983-01-19
IE46087B1 (en) 1983-02-23
IT1126216B (it) 1986-05-14
CH635079A5 (de) 1983-03-15
NL930026I2 (nl) 1993-11-01
PL202177A1 (pl) 1978-09-25
NL185563B (nl) 1989-12-18
AT362379B (de) 1981-05-11
CS219333B2 (en) 1983-03-25
FI67374C (fi) 1985-03-11
SU976847A3 (ru) 1982-11-23
RO72905A (ro) 1981-11-04
DE2751258A1 (de) 1978-06-01
NL185563C (nl) 1990-05-16
DK500477A (da) 1978-05-18
ES464044A1 (es) 1978-08-01
BE860774A (fr) 1978-05-16
MY8500382A (en) 1985-12-31
DD133563A5 (de) 1979-01-10
SE7712944L (sv) 1978-05-18
NO147029B (no) 1982-10-11
CY1246A (en) 1984-08-31
JPS58113153A (ja) 1983-07-05
YU270777A (en) 1983-02-28
NO773901L (no) 1978-05-19
MX4682E (es) 1982-07-28
AU3062677A (en) 1979-05-24
DK156057B (da) 1989-06-19
JPS6225658B2 (US20080293856A1-20081127-C00150.png) 1987-06-04
IE46087L (en) 1978-05-17
PL109672B1 (en) 1980-06-30
ATA816377A (de) 1980-10-15
PH13611A (en) 1980-08-05
FR2371430B1 (US20080293856A1-20081127-C00150.png) 1980-06-27
DK156057C (da) 1989-11-13
CA1092107A (en) 1980-12-23
FR2371430A1 (fr) 1978-06-16
PT67260A (en) 1977-12-01

Similar Documents

Publication Publication Date Title
JPS5368785A (en) Heterocycltc compound
JPS5363335A (en) Triisubstitutedd11phenyll2*3*4*55 tetrahydroo1hh33benzazepine compound
JPS5576895A (en) Novel 4*66diioo*aminoglycosyl**1*33 diaminocycritols
JPS52151348A (en) Compound
JPS5363424A (en) Bitumious compound
JPS52125197A (en) Transshexahydroopyridooindole compound
JPS5325567A (en) 22phenylaminooimidazolinee*2* compound
JPS5353618A (en) Nnsubstituted biscarbamoylsulfide compound
JPS5321159A (en) 1*55disubstitutedd22pyrrolidones
JPS52133974A (en) 1*33dihydrooheteroarylspiro*isobenzolane*
JPS5337653A (en) 111deoxyy111oxaprostaglandin compound
JPS5359686A (en) Compound
JPS5295689A (en) Betaalactummcontaining compound
JPS5325537A (en) Compound
JPS537677A (en) 2*66methanoo2hh11 benzooxosines
JPS5321105A (en) Stabilized 1*1*11trichloroethane
JPS5293772A (en) Indolinospiropyran compound
MY8400092A (en) 21 halogenopregnane compounds
JPS5365892A (en) 33*22aminoethylthio**66*11hydroxyethyl* 77oxoo11azabicyclo*3*2*0*heptt22 enee22carboxylate
JPS52156897A (en) 77*alphaa*2*33dihydroo22oxoo1hh benzimidazolee11ylcarbonylamino** arylacetoamide*cephalospolines
JPS5323995A (en) Antiibacterial compound
JPS5373576A (en) Substituted 2*1*33benzothiadiazine compound
JPS5321222A (en) Bissbenzoxazolyl compound
JPS52156899A (en) Compound
JPS5353692A (en) Antiiworm compound